Loading clinical trials...
Loading clinical trials...
Effect of Gene Variants on Dopamine Receptor Natriuretic Responses (RMC033)
Conditions
Interventions
fenoldopam
Placebo
Locations
1
United States
University of Virginia
Charlottesville, Virginia, United States
Start Date
June 1, 2007
Primary Completion Date
March 1, 2008
Completion Date
June 1, 2013
Last Updated
January 23, 2013
NCT02417740
NCT07480265
NCT07073820
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
University of Virginia
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions